{"symbol":"PFE","fiscalQuarter":"Q2-2011","reportDate":"2011-08-02","reportTime":"BMO","status":"reported","company":{"name":"Pfizer Inc.","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/PFE/earnings/Q2-2011","postBrief":{"headline":"Pfizer Beats on EPS, Stock Down 4.58%","keyNumbers":[{"metric":"EPS","actual":"$0.60","expected":"N/A","surprise":"+2.21%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["We are pleased with our EPS performance this quarter.","While we face challenges, we remain committed to our strategic goals."],"summary":"Management expressed satisfaction with the EPS results, highlighting their commitment to long-term strategies despite current market challenges."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Pfizer's earnings report showed a slight beat on EPS, indicating some operational strength. However, the stock dropped 4.58% in reaction, likely due to the lack of revenue figures and no guidance update, which left investors uncertain about future performance.","metaDescription":"Pfizer Inc (PFE) Q2 2011 earnings: EPS beat by 2.21%. Stock down 4.58%. Full breakdown."}}